Investors
Amplyx is a privately held company advancing the clinical development of fosmanogepix and MAU868 for treatment of life-threatening diseases. Our largest investors are:
Amplyx is a privately held company advancing the clinical development of fosmanogepix and MAU868 for treatment of life-threatening diseases. Our largest investors are:
Milestones Along Our Journey
Heidi Chokeir, Ph.D.
Canale Communications
(619) 849-5377 | heidi@canalecomm.com